Jacquelyn Roth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacquelyn Roth has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Bernice Yu
Mount Sinai Health System, Plastic and Reconstructive Surgery, New York, United States, New York
7 shared publicationsEthan Fung
6 shared publicationsPeter J. Taub
Icahn School of Medicine at Mount Sinai
6 shared publications- Peter William Henderson
Division of Plastic and Reconstructive Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, 10 Union Square East, Suite 2 L, New York, NY 10003, United States
6 shared publications - Bernice Z. Yu
Division of Plastic and Reconstructive Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
4 shared publications Maxwell Godek
Icahn School of Medicine at Mount Sinai
4 shared publications
Latest Publications
- 6 July 2026
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
Interest in Robotics Outpaces Access: Results from A Survey of Practicing Plastic Surgeons.
While the launch of the da Vinci Surgical System catalyzed the expansion of robotic surgery across disciplines, adoption in plastic surgery remains modest. To explore this disconnect, this study surveys plastic surgeons to gauge interest, utilization, and perceived barriers to robotic surgery adoption. A 15-question survey on training, access, interest and barriers to robotic procedures was developed on Qualtrics and distributed via email to members of the American Society of Plastic Surgeons (ASPS) in May 2024. Descriptive statistics were used to summarize responses. 123 responses were collected among 3,512 survey recipients. Among respondents, 84.6% reported having to a surgical robot, however only 13.8% had training on robotic systems during residency, and only 12.2% utilized the technology for plastic surgery procedures. Interest in robotics was noted among 47.9% of respondents, particularly for DIEP flap procedures (65.5%), rectus/VRAM flaps (58.2%), and hernia repairs (27.3%). Key barriers to adoption included training requirements (63.9%), lack of demand (60.2%), increased operative time (54.6%), and financial concerns (26.9%). Additional obstacles cited were credentialing difficulties, and skepticism about the necessity of robotics in plastic surgery. The present survey identified inadequate training, high costs, and limited demand as key barriers to the adoption of robotics in plastic surgery, reflecting the current lack of robotic integration into residency curricula, as well as the substantial investment and maintenance costs associated with robotic systems. Nevertheless, the strong interest in robotics highlights the need for expanded training programs, promotion of clinical benefits and research quantifying potential downstream savings to overcome these barriers.
- 6 July 2026
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
Interest in Robotics Outpaces Access: Results from A Survey of Practicing Plastic Surgeons.
While the launch of the da Vinci Surgical System catalyzed the expansion of robotic surgery across disciplines, adoption in plastic surgery remains modest. To explore this disconnect, this study surveys plastic surgeons to gauge interest, utilization, and perceived barriers to robotic surgery adoption. A 15-question survey on training, access, interest and barriers to robotic procedures was developed on Qualtrics and distributed via email to members of the American Society of Plastic Surgeons (ASPS) in May 2024. Descriptive statistics were used to summarize responses. 123 responses were collected among 3,512 survey recipients. Among respondents, 84.6% reported having to a surgical robot, however only 13.8% had training on robotic systems during residency, and only 12.2% utilized the technology for plastic surgery procedures. Interest in robotics was noted among 47.9% of respondents, particularly for DIEP flap procedures (65.5%), rectus/VRAM flaps (58.2%), and hernia repairs (27.3%). Key barriers to adoption included training requirements (63.9%), lack of demand (60.2%), increased operative time (54.6%), and financial concerns (26.9%). Additional obstacles cited were credentialing difficulties, and skepticism about the necessity of robotics in plastic surgery. The present survey identified inadequate training, high costs, and limited demand as key barriers to the adoption of robotics in plastic surgery, reflecting the current lack of robotic integration into residency curricula, as well as the substantial investment and maintenance costs associated with robotic systems. Nevertheless, the strong interest in robotics highlights the need for expanded training programs, promotion of clinical benefits and research quantifying potential downstream savings to overcome these barriers.
- 16 January 2026
- Published by SAGE Publications in Plastic Surgery
Primary Language as a Predictor of Perioperative Opioid Consumption and Clinical Outcomes in Breast Reconstruction: A Retrospective Cohort Study
Introduction: Language barriers can impair communication and affect perioperative outcomes. This study examines the perioperative impact of limited English proficiency (LEP) on opioid consumption for pain management and clinical outcomes in both autologous breast reconstruction (ABR) and implant-based breast reconstruction (IBR). Methods: A retrospective cohort study (2019-2023) utilized electronic health records to categorize breast reconstruction patients by primary language proficiency. Outcomes included opioid consumption (postoperative and total morphine milligram equivalents [MME]), complications, reoperations, emergency department visits, and readmissions. Analyses used comparative tests and multivariate regressions. Subgroup analyses were conducted for reconstruction type. Results: Among 1706 patients (15% non-English-speaking), non-English speakers demonstrated significantly lower postoperative (58 ± 77 vs 88 ± 121, p < .001) and total (166 ± 121 vs 207 ± 146, p < .001) opioid consumption, with Cantonese speakers having the lowest odds of opioid consumption. In ABR, non-English speakers had reduced postoperative (74 ± 89 vs 115 ± 147, p < .001) and total (203 ± 126 vs 256 ± 166, p < .001) opioid requirements (β= −40, p = .026) but higher odds of seroma formation (OR = 2.78, p = 0.030). In IBR, non-English speakers similarly used fewer opioids postoperatively (28 ± 35 vs 56 ± 70, p < .001) and in total (98 ± 73 vs 152 ± 94, p < .001), and also demonstrated increased odds of seroma formation (OR = 4.66, p = .018). Conclusion: Language proficiency is associated with differences in opioid consumption and clinical outcomes following breast reconstruction. These findings underscore the importance of considering language barriers when designing pain management strategies for patients with LEP.
- 16 January 2026
- Published by SAGE Publications in Plastic Surgery
Primary Language as a Predictor of Perioperative Opioid Consumption and Clinical Outcomes in Breast Reconstruction: A Retrospective Cohort Study
Introduction: Language barriers can impair communication and affect perioperative outcomes. This study examines the perioperative impact of limited English proficiency (LEP) on opioid consumption for pain management and clinical outcomes in both autologous breast reconstruction (ABR) and implant-based breast reconstruction (IBR). Methods: A retrospective cohort study (2019-2023) utilized electronic health records to categorize breast reconstruction patients by primary language proficiency. Outcomes included opioid consumption (postoperative and total morphine milligram equivalents [MME]), complications, reoperations, emergency department visits, and readmissions. Analyses used comparative tests and multivariate regressions. Subgroup analyses were conducted for reconstruction type. Results: Among 1706 patients (15% non-English-speaking), non-English speakers demonstrated significantly lower postoperative (58 ± 77 vs 88 ± 121, p < .001) and total (166 ± 121 vs 207 ± 146, p < .001) opioid consumption, with Cantonese speakers having the lowest odds of opioid consumption. In ABR, non-English speakers had reduced postoperative (74 ± 89 vs 115 ± 147, p < .001) and total (203 ± 126 vs 256 ± 166, p < .001) opioid requirements (β= −40, p = .026) but higher odds of seroma formation (OR = 2.78, p = 0.030). In IBR, non-English speakers similarly used fewer opioids postoperatively (28 ± 35 vs 56 ± 70, p < .001) and in total (98 ± 73 vs 152 ± 94, p < .001), and also demonstrated increased odds of seroma formation (OR = 4.66, p = .018). Conclusion: Language proficiency is associated with differences in opioid consumption and clinical outcomes following breast reconstruction. These findings underscore the importance of considering language barriers when designing pain management strategies for patients with LEP.
- 1 January 2026
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 96 (1) , 19-24
Insurance Type Does Not Impact Adverse Outcomes Following Breast Reduction Surgery
Background: Previous literature suggests that treatment delays and poorer baseline health among patients with Medicare and Medicaid, compared to those with private insurance, contribute to worse outcomes across a range of procedures. However, the impact of insurance type on breast reduction surgery remains underexplored. This study evaluates disparities in breast reduction outcomes among patients with private insurance, Medicaid, and Medicare. Methods: A retrospective chart review was conducted of patients who had undergone breast reduction surgery between 2019 and 2023. Patient demographics were collected, and medical insurance was categorized as private, Medicare, or Medicaid. Outcomes studied included complications and procedure length. Regression analyses assessed the association between insurance types and postoperative outcomes. Statistical significance was set at P < 0.05. Results: Of the 1085 patients included, 627 had private insurance (57.8%), 363 had Medicaid insurance (33.5%), and 95 had Medicare insurance (8.8%). Age, race, ethnicity, and resected tissue weight differed significantly among the groups. Univariate analysis showed that patients with Medicare insurance had higher odds of postoperative infection (OR, 3.48; P = 0.009), and patients with Medicaid insurance had lower odds of complications requiring reoperation (OR, 0.35; P = 0.04). However, neither association remained significant in multivariate analysis. In contrast, operative time was significantly shorter for patients with Medicaid insurance compared to those with private insurance in both univariate (Beta = −10.14; P = 0.003) and multivariate models (Beta = −11.30; P = 0.006). Conclusion: While insurance type was not independently associated with postoperative complications following breast reduction surgery, patients with Medicaid insurance experienced significantly shorter operative times, suggesting that insurance type may influence some aspects of intraoperative care, whereas broader social determinants of health likely have a greater impact on postoperative outcomes.
- 1 January 2026
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 96 (1) , 19-24
Insurance Type Does Not Impact Adverse Outcomes Following Breast Reduction Surgery
Background: Previous literature suggests that treatment delays and poorer baseline health among patients with Medicare and Medicaid, compared to those with private insurance, contribute to worse outcomes across a range of procedures. However, the impact of insurance type on breast reduction surgery remains underexplored. This study evaluates disparities in breast reduction outcomes among patients with private insurance, Medicaid, and Medicare. Methods: A retrospective chart review was conducted of patients who had undergone breast reduction surgery between 2019 and 2023. Patient demographics were collected, and medical insurance was categorized as private, Medicare, or Medicaid. Outcomes studied included complications and procedure length. Regression analyses assessed the association between insurance types and postoperative outcomes. Statistical significance was set at P < 0.05. Results: Of the 1085 patients included, 627 had private insurance (57.8%), 363 had Medicaid insurance (33.5%), and 95 had Medicare insurance (8.8%). Age, race, ethnicity, and resected tissue weight differed significantly among the groups. Univariate analysis showed that patients with Medicare insurance had higher odds of postoperative infection (OR, 3.48; P = 0.009), and patients with Medicaid insurance had lower odds of complications requiring reoperation (OR, 0.35; P = 0.04). However, neither association remained significant in multivariate analysis. In contrast, operative time was significantly shorter for patients with Medicaid insurance compared to those with private insurance in both univariate (Beta = −10.14; P = 0.003) and multivariate models (Beta = −11.30; P = 0.006). Conclusion: While insurance type was not independently associated with postoperative complications following breast reduction surgery, patients with Medicaid insurance experienced significantly shorter operative times, suggesting that insurance type may influence some aspects of intraoperative care, whereas broader social determinants of health likely have a greater impact on postoperative outcomes.
- Open Access
- 19 December 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 115, 467-479
Assessing the costs of academic engagement in plastic surgery in the United States
- 19 December 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 115, 467-479
Open AccessAssessing the costs of academic engagement in plastic surgery in the United States
- 11 December 2025
- Published by SAGE Publications in Plastic Surgery
- Vol. 34 (4) , 687-695
The Weight of Obesity on Timely Breast Reconstruction Surgery
Background: Delayed care carries both clinical and psychosocial consequences for patients undergoing breast reconstruction. This study evaluated whether elevated BMI is associated with delays in post-mastectomy reconstructive care, with the aim of identifying potential contributors to outcome disparities among higher-weight patients. Methods: A single institution, retrospective review of breast reconstruction patients between 2017 and 2023 was conducted. Patients were stratified by World Health Organization BMI classifications. Outcomes comprised intervals between diagnosis and plastic and reconstructive surgery (PRS) consultation, index procedure, and final procedure. Regression models evaluated associations between BMI and clinical timelines. Results: Of the 1659 patients included, 26 were underweight (1.6%), 599 were healthy weight (36.1%), 520 were overweight (31.3%), 322 were Class I obese (19.4%), 144 were Class II obese (8.7%), and 48 were Class III obese (2.9%). On univariable analysis, prolonged intervals between diagnosis to index procedure were observed for Class I ( β = 0.187, P = 0.01) and Class II ( β = 0.276, P = 0.004) obesity patients; however, these findings did not persist after adjusting for demographics, operative details, and comorbidities. Intervals between diagnosis and PRS consult did not show significant differences among BMI classes. Conclusion: While extended intervals to the index reconstructive procedure among obese patients suggest care delays occur after PRS consultation, the absence of significant associations in multivariable analysis indicates that comorbidities and sociodemographic factors are the primary contributors. These findings offer reassurance that elevated BMI does not independently impede timely receipt of breast reconstruction.
- 11 December 2025
- Published by SAGE Publications in Plastic Surgery
- Vol. 34 (4) , 687-695
The Weight of Obesity on Timely Breast Reconstruction Surgery
Background: Delayed care carries both clinical and psychosocial consequences for patients undergoing breast reconstruction. This study evaluated whether elevated BMI is associated with delays in post-mastectomy reconstructive care, with the aim of identifying potential contributors to outcome disparities among higher-weight patients. Methods: A single institution, retrospective review of breast reconstruction patients between 2017 and 2023 was conducted. Patients were stratified by World Health Organization BMI classifications. Outcomes comprised intervals between diagnosis and plastic and reconstructive surgery (PRS) consultation, index procedure, and final procedure. Regression models evaluated associations between BMI and clinical timelines. Results: Of the 1659 patients included, 26 were underweight (1.6%), 599 were healthy weight (36.1%), 520 were overweight (31.3%), 322 were Class I obese (19.4%), 144 were Class II obese (8.7%), and 48 were Class III obese (2.9%). On univariable analysis, prolonged intervals between diagnosis to index procedure were observed for Class I ( β = 0.187, P = 0.01) and Class II ( β = 0.276, P = 0.004) obesity patients; however, these findings did not persist after adjusting for demographics, operative details, and comorbidities. Intervals between diagnosis and PRS consult did not show significant differences among BMI classes. Conclusion: While extended intervals to the index reconstructive procedure among obese patients suggest care delays occur after PRS consultation, the absence of significant associations in multivariable analysis indicates that comorbidities and sociodemographic factors are the primary contributors. These findings offer reassurance that elevated BMI does not independently impede timely receipt of breast reconstruction.
- 17 September 2025
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 42 (07) , 559-565
Simultaneous Microsurgery During Bilateral Autologous Breast Reconstruction Reduces Ischemia Time Without Increasing Complications
In bilateral deep inferior epigastric perforator (DIEP) flap reconstruction procedures, the microsurgical anastomoses are usually performed consecutively, where one side is completed before the other side is started. However, when a co-surgeon model and loupe magnification are used, it is possible to perform both sides simultaneously. This study assesses the implications of simultaneous versus consecutive microsurgery on ischemia time and postoperative outcomes in bilateral DIEP flap reconstruction.A retrospective chart review was conducted on bilateral DIEP flap breast reconstruction patients between 2017 and 2023. Ischemia time was used to categorize the microsurgical anastomosis, with an overlap of 10 or more minutes between sides classified as “simultaneous microsurgery,” and an overlap of less than 10 minutes classified as “consecutive microsurgery.” Data were collected on patient demographics, total ischemia time (total time when one or both sides of the abdomen were undergoing microsurgical anastomoses), total operating time, postoperative complications, 90-day postoperative events, hospital length of stay (LOS), and morphine milligram equivalents (MME) required for pain management. Regression analyses assessed the impact of simultaneous versus consecutive microsurgery on key outcomes. Statistical significance was set at p < 0.05.Seventy-four patients met the inclusion criteria for this study. Thirty-one (42%) had undergone simultaneous microsurgery, and 43 (58%) had undergone consecutive microsurgery. There were no significant differences between the two groups in age, body mass index (BMI), race, ethnicity, or baseline comorbidities. Univariate analysis revealed a statistically significant reduction in total ischemia time associated with simultaneous microsurgery (111 minutes vs. 147 minutes; p < 0.001), and no differences in total operating time, complications, 90-day postoperative events, LOS, or MME. These findings were unchanged on multivariate regression controlling for age, BMI, comorbidities, and flap weight.Simultaneous microsurgery during bilateral DIEP flap reconstruction significantly reduces total ischemia time without increasing complications, hospital LOS, or pain management requirements.
- 17 September 2025
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 42 (07) , 559-565
Simultaneous Microsurgery During Bilateral Autologous Breast Reconstruction Reduces Ischemia Time Without Increasing Complications
In bilateral deep inferior epigastric perforator (DIEP) flap reconstruction procedures, the microsurgical anastomoses are usually performed consecutively, where one side is completed before the other side is started. However, when a co-surgeon model and loupe magnification are used, it is possible to perform both sides simultaneously. This study assesses the implications of simultaneous versus consecutive microsurgery on ischemia time and postoperative outcomes in bilateral DIEP flap reconstruction.A retrospective chart review was conducted on bilateral DIEP flap breast reconstruction patients between 2017 and 2023. Ischemia time was used to categorize the microsurgical anastomosis, with an overlap of 10 or more minutes between sides classified as “simultaneous microsurgery,” and an overlap of less than 10 minutes classified as “consecutive microsurgery.” Data were collected on patient demographics, total ischemia time (total time when one or both sides of the abdomen were undergoing microsurgical anastomoses), total operating time, postoperative complications, 90-day postoperative events, hospital length of stay (LOS), and morphine milligram equivalents (MME) required for pain management. Regression analyses assessed the impact of simultaneous versus consecutive microsurgery on key outcomes. Statistical significance was set at p < 0.05.Seventy-four patients met the inclusion criteria for this study. Thirty-one (42%) had undergone simultaneous microsurgery, and 43 (58%) had undergone consecutive microsurgery. There were no significant differences between the two groups in age, body mass index (BMI), race, ethnicity, or baseline comorbidities. Univariate analysis revealed a statistically significant reduction in total ischemia time associated with simultaneous microsurgery (111 minutes vs. 147 minutes; p < 0.001), and no differences in total operating time, complications, 90-day postoperative events, LOS, or MME. These findings were unchanged on multivariate regression controlling for age, BMI, comorbidities, and flap weight.Simultaneous microsurgery during bilateral DIEP flap reconstruction significantly reduces total ischemia time without increasing complications, hospital LOS, or pain management requirements.
- 17 September 2025
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 42 (07) , 554-558
Population Assessment of Anatomic Eligibility for Robotic-Assisted DIEP Flap
Compared with traditional deep inferior epigastric perforator (DIEP) flap breast reconstruction procedures, robotic-assisted DIEP (R-DIEP) minimizes abdominal wall morbidity by reducing fascial incision length. Optimal R-DIEP candidates have large perforators with short intramuscular courses, but no large-scale studies have quantified their prevalence. This study aims to identify the proportion of patients who are anatomically eligible for R-DIEP.A retrospective review of patients who underwent magnetic resonance angiography perforator mapping prior to DIEP flap breast reconstruction between 2019 and 2023 was conducted. Patient demographics were collected. “Dominant perforator” was defined as the largest perforator at or below the level of the umbilicus. The intramuscular course of each perforator was calculated as the hypotenuse of a theoretical prism connecting its entry and exit points with respect to the rectus abdominis muscle. Perforator diameter was measured at the anterior rectus sheath. “Conservative” (intramuscular course ≤ 2.5 cm) and “liberal” (intramuscular course ≤ 5 cm) eligibility criteria were applied. Perforator diameter > 2 mm was used as a secondary criterion.A total of 574 dominant perforators were identified in 287 patients. The average intramuscular length of each perforator was 3.8 ± 1.9 cm (range: 0–11.0 cm). Twenty-nine percent of dominant perforators (n = 165) had an intramuscular course length ≤ 2.5 cm, 77% (n = 441) had an intramuscular course length ≤ 5 cm, and 2.3% (n = 13) were paramuscular (no intramuscular course). Forty-six percent of patients (n = 132) had at least one dominant perforator (i.e., left- or right-sided) with an intramuscular course ≤ 2.5 cm, and 93% of patients (n = 268) had at least one dominant perforator with an intramuscular course ≤ 5 cm. Thirty-one percent of dominant perforators (n = 185) had a diameter > 2 mm and an intramuscular course ≤ 2.5 cm, and 49% of dominant perforators (n = 281) had a diameter > 2 mm and an intramuscular course ≤ 5 cm.A substantial portion of the population is anatomically eligible for R-DIEP breast reconstruction, especially when liberal criteria are applied.
- 17 September 2025
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 42 (07) , 554-558
Population Assessment of Anatomic Eligibility for Robotic-Assisted DIEP Flap
Compared with traditional deep inferior epigastric perforator (DIEP) flap breast reconstruction procedures, robotic-assisted DIEP (R-DIEP) minimizes abdominal wall morbidity by reducing fascial incision length. Optimal R-DIEP candidates have large perforators with short intramuscular courses, but no large-scale studies have quantified their prevalence. This study aims to identify the proportion of patients who are anatomically eligible for R-DIEP.A retrospective review of patients who underwent magnetic resonance angiography perforator mapping prior to DIEP flap breast reconstruction between 2019 and 2023 was conducted. Patient demographics were collected. “Dominant perforator” was defined as the largest perforator at or below the level of the umbilicus. The intramuscular course of each perforator was calculated as the hypotenuse of a theoretical prism connecting its entry and exit points with respect to the rectus abdominis muscle. Perforator diameter was measured at the anterior rectus sheath. “Conservative” (intramuscular course ≤ 2.5 cm) and “liberal” (intramuscular course ≤ 5 cm) eligibility criteria were applied. Perforator diameter > 2 mm was used as a secondary criterion.A total of 574 dominant perforators were identified in 287 patients. The average intramuscular length of each perforator was 3.8 ± 1.9 cm (range: 0–11.0 cm). Twenty-nine percent of dominant perforators (n = 165) had an intramuscular course length ≤ 2.5 cm, 77% (n = 441) had an intramuscular course length ≤ 5 cm, and 2.3% (n = 13) were paramuscular (no intramuscular course). Forty-six percent of patients (n = 132) had at least one dominant perforator (i.e., left- or right-sided) with an intramuscular course ≤ 2.5 cm, and 93% of patients (n = 268) had at least one dominant perforator with an intramuscular course ≤ 5 cm. Thirty-one percent of dominant perforators (n = 185) had a diameter > 2 mm and an intramuscular course ≤ 2.5 cm, and 49% of dominant perforators (n = 281) had a diameter > 2 mm and an intramuscular course ≤ 5 cm.A substantial portion of the population is anatomically eligible for R-DIEP breast reconstruction, especially when liberal criteria are applied.
- Open Access
- 17 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6532
Patient Race Independently Predicts Timeliness of Breast Cancer Reconstructive Care
Background/Objectives: While higher complication rates among minority patients following breast reconstruction are documented, the role of lengthier care intervals in perpetuating these disparities remains unclear. This study assesses whether race influences the timeliness of breast reconstructive care for patients following breast cancer diagnoses. Methods: A retrospective analysis of breast reconstruction patients between 2017 and 2023 was conducted. Primary outcomes comprised intervals from breast cancer diagnosis to plastic and reconstructive surgery (PRS) consultation, index reconstructive procedure, and final reconstructive procedure. Regression models assessed the impact of race on outcomes. Results: Of the 1662 patients included, 745 identified as White (44.8%), 337 as Black (20.3%), 199 as Asian (12.0%), 278 as “Other” races (16.7%), and 103 did not specify race (6.2%). Baseline characteristics differed significantly across groups (p < 0.001). Latino patients comprised the majority of the ‘Other’ (50%) and ‘Unknown’ (75%) race categories. On multivariable regression, intervals to PRS consultation and index procedure were significantly prolonged for Black (β = 0.307, p = 0.001 and β = 0.254, p < 0.001, respectively) and “Other” race (β = 0.332, p = 0.006 and β = 0.283, p = 0.001) patients, while Black patients also faced significantly longer intervals to the final procedure (β = 0.213, p = 0.001). Conclusions: Prolonged care intervals for non-White patients persist at multiple stages of breast reconstruction, potentially exacerbating outcome disparities. The present study implicates logistical barriers such as fragmented care, scheduling, and transportation challenges, as well as provider- or patient-level bias, as contributors to race-based disparities in timely care.
- 17 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6532
Open AccessPatient Race Independently Predicts Timeliness of Breast Cancer Reconstructive Care
Background/Objectives: While higher complication rates among minority patients following breast reconstruction are documented, the role of lengthier care intervals in perpetuating these disparities remains unclear. This study assesses whether race influences the timeliness of breast reconstructive care for patients following breast cancer diagnoses. Methods: A retrospective analysis of breast reconstruction patients between 2017 and 2023 was conducted. Primary outcomes comprised intervals from breast cancer diagnosis to plastic and reconstructive surgery (PRS) consultation, index reconstructive procedure, and final reconstructive procedure. Regression models assessed the impact of race on outcomes. Results: Of the 1662 patients included, 745 identified as White (44.8%), 337 as Black (20.3%), 199 as Asian (12.0%), 278 as “Other” races (16.7%), and 103 did not specify race (6.2%). Baseline characteristics differed significantly across groups (p < 0.001). Latino patients comprised the majority of the ‘Other’ (50%) and ‘Unknown’ (75%) race categories. On multivariable regression, intervals to PRS consultation and index procedure were significantly prolonged for Black (β = 0.307, p = 0.001 and β = 0.254, p < 0.001, respectively) and “Other” race (β = 0.332, p = 0.006 and β = 0.283, p = 0.001) patients, while Black patients also faced significantly longer intervals to the final procedure (β = 0.213, p = 0.001). Conclusions: Prolonged care intervals for non-White patients persist at multiple stages of breast reconstruction, potentially exacerbating outcome disparities. The present study implicates logistical barriers such as fragmented care, scheduling, and transportation challenges, as well as provider- or patient-level bias, as contributors to race-based disparities in timely care.